Rapt Therapeutics Inc

Rapt Therapeutics Inc

Health CarePharmaceuticals and Biotechnology
  • Price (USD)21.05
  • Today's Change0.14 / 0.67%
  • Shares traded221.25k
  • 1 Year change+24.70%
  • Beta0.1899
Data delayed at least 15 minutes, as of Jun 07 2023 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Events & Activity

  • RAPT:NMQ price moved over +1.01% to 21.06
  • RAPT:NMQ price falls below 15-day moving average to 20.60 at 10:50 BST
  • RAPT:NMQ price falls below 15-day moving average to 20.45 at 10:36 BST

Key statistics

On Wednesday, Rapt Therapeutics Inc (RAPT:NMQ) closed at 21.05, 58.15% above the 52 week low of 13.31 set on Jun 13, 2022.
52-week range
13.31Jun 13 202232.45Aug 25 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close20.91
Average volume238.63k
Shares outstanding34.35m
Free float33.83m
P/E (TTM)--
Market cap718.15m USD
EPS (TTM)-2.65
Data delayed at least 15 minutes, as of Jun 07 2023 21:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.